| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |